Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,743 | 16,030 | 16,225 | 14,876 | 14,456 |
| Receivables | 99,129 | 95,449 | 89,204 | 100,602 | 104,933 |
| Inventories | 29,104 | 29,426 | 31,314 | 36,400 | 41,109 |
| Income taxes - deferred | N/A | N/A | N/A | 11,992 | 9,123 |
| Other current assets | 0 | 0 | 19,865 | 0 | 0 |
| TOTAL | $153,245 | $151,644 | $166,953 | $175,673 | $179,349 |
| Non-Current Assets | |||||
| PPE Net | 81,342 | 79,622 | 87,336 | 95,900 | 97,615 |
| Intangibles | 139,338 | 139,672 | 138,276 | 142,359 | 151,257 |
| Other Non-Current Assets | 20,676 | 17,859 | 34,166 | 7,669 | 11,279 |
| TOTAL | $241,356 | $237,153 | $259,778 | $245,928 | $260,151 |
| Total Assets | $394,601 | $388,797 | $426,731 | $421,601 | $439,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,544 | 2,976 | 3,417 | 1,145 | 506 |
| Accounts payable and accrued liabilities | 32,557 | 28,632 | 25,490 | 25,407 | 19,721 |
| Accrued Expenses | 17,371 | 22,920 | 14,081 | 12,553 | 9,825 |
| TOTAL | $69,556 | $67,411 | $61,874 | $50,084 | $40,007 |
| Non-Current Liabilities | |||||
| Long Term Debt | 86,104 | 110,224 | 124,684 | 88,035 | 95,121 |
| Deferred Revenues | 3,233 | 2,632 | 2,085 | 1,709 | 3,198 |
| Other Non-Current Liabilities | 24,684 | 20,866 | 19,761 | 10,875 | 15,416 |
| TOTAL | $110,788 | $131,090 | $144,445 | $113,371 | $123,887 |
| Total Liabilities | $180,344 | $198,501 | $206,319 | $163,455 | $163,894 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,668 | 52,070 | 55,256 | 63,252 | 66,417 |
| Common Shares | 474 | 484 | 509 | 546 | 546 |
| Retained earnings | 141,448 | 110,237 | 97,947 | 79,247 | 88,309 |
| Other shareholders' equity | -497 | -2,757 | 409 | -11 | 0 |
| TOTAL | $214,257 | $190,296 | $220,412 | $258,146 | $275,606 |
| Total Liabilities And Equity | $394,601 | $388,797 | $426,731 | $421,601 | $439,500 |